X0407 4 2023-05-31 0001781174 Acrivon Therapeutics, Inc. ACRV 0001950499 Blume-Jensen Peter C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true true President and CEO false Common Stock 2023-05-31 4 M 0 33605 3.88 A 2403702 D Common Stock 320705 I See footnote Stock Option (Right to Buy) 3.88 2023-05-31 4 M 0 33605 0 D 2032-03-22 Common Stock 33605 90855 D Stock Option (Right to Buy) 3.88 2032-03-22 Common Stock 62230 62230 I See footnote These securities are held by Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The shares subject to the option vested or shall vest quarterly on the last day of each quarter for 16 quarters following January 1, 2022, in each case subject to the Reporting Person's continuous service through each such vesting date. The expiration date for these options was inadvertently reported as April 5, 2032 on the Form 3 filed by the Reporting Person on November 9, 2022, and has been corrected as of this Form 4. Exhibit List - Exhibit 24 - Power of Attorney /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2023-06-01